Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G

PLoS Biology

Volumn 2, Issue 9, 2004, Pages

  Sawyer, Sara L ^a   Emerman, Michael ^a   Malik, Harmit S ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B EDITING CATALYTIC POLYPEPTIDE 3G; ISOENZYME; PROTEIN; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; VIRION INFECTIVITY FACTOR; VIRULENCE FACTOR; APOBEC2 PROTEIN, HUMAN; APOLIPOPROTEIN B MRNA EDITING ENZYME; CEM15 PROTEIN, HUMAN; CYTIDINE DEAMINASE; DEAMINASE; DNA; MUSCLE PROTEIN; PRIMER DNA; REPRESSOR PROTEIN; VIF PROTEIN;

AMINO ACID SEQUENCE; APOBEC3G GENE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBUNIT; EVOLUTIONARY ADAPTATION; GENE; HOST RESISTANCE; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMATE; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RETROVIRUS INFECTION; RNA EDITING; SEQUENCE HOMOLOGY; VIRION; VIRUS GENE; VIRUS MUTATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; CATALYSIS; CHEMISTRY; DNA SEQUENCE; EVOLUTION; GENETIC DATABASE; GENETIC POLYMORPHISM; GENETICS; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR GENETICS; MUTATION; PAN TROGLODYTES; PHYLOGENY; PROTEIN TERTIARY STRUCTURE; STATISTICAL MODEL; TIME; TRANSPOSON; VIROLOGY; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; PRIMATES; UNIDENTIFIED RETROVIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CATALYSIS; CYTIDINE DEAMINASE; DATABASES, GENETIC; DNA; DNA PRIMERS; DNA TRANSPOSABLE ELEMENTS; EVOLUTION; EVOLUTION, MOLECULAR; GENE PRODUCTS, VIF; GENES, VIRAL; GENOME, HUMAN; HIV; HIV INFECTIONS; HUMANS; LIKELIHOOD FUNCTIONS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION; NUCLEOSIDE DEAMINASES; PAN TROGLODYTES; PHYLOGENY; POLYMORPHISM, GENETIC; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; RNA EDITING; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRUS REPLICATION;

EID: 19344362934     PISSN: 15449173     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pbio.0020275     Document Type: Article

References (50)

1. Anisimova M, Bielawski JP, Yang Z (2002) Accuracy and power of Bayes prediction of amino acid sites under positive selection. Mol Biol Evol 19: 950-958.
2. Aufsatz W, Mette MF, van der Winden J, Matzke AJ, Matzke M (2002) RNA-directed DNA methylation in Arabidopsis. Proc Natl Acad Sci U S A 99: (Suppl 4) 16499-16506.
3. Bogerd HP, Doehle BP, Wiegand HL, Cullen BR (2004) A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A 101: 3770-3774.
4. Chan L, Chang BHJ, Nakamuta M, Li WH, Smith LC (1997) Apobec-1 and apolipoprotein B mRNA editing. Biochim Biophys Acta 1345: 11-26.
5. Comeron JM (1999) K-estimator: Calculation of the number of nucleotide substitutions per site and the confidence intervals. Bioinformatics 15: 763-764.
6. Conticello SG, Harris RS, Neuberger MS (2003) The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol 13: 2009-2013.
7. Endo T, Ikeo K, Gojobori T (1996) Large-scale search for genes on which positive selection may operate. Mol Biol Evol 13: 685-690.
8. Fugmann SD, Schatz DG (2002) One AID to unite them all. Science 295: 1244-1245.
9. Gu Y, Sundquist WI (2003) Good to CU. Nature 424: 21-22.
10. Harris RS, Petersen-Mahrt SK, Neuberger MS (2002) RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol Cell 10: 1247-1253.
11. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA determination mediates innate immunity to retroviral infection. Cell 113: 803-809.
12. Hughes AL, Nei M (1988) Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 335: 167-170.
13. Hurst LD (2002) The Ka/Ks ratio: Diagnosing the form of sequence evolution. Trends Genet 18: 486-487.
14. Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, et al. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79: 285-296.
15. Ketting RF, Haverkamp TH, van Luenen HG, Plasterk RH (1999) Mut-7 of C. elegans required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell 99: 133-141.
16. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
17. Lau P, Zhu H, Baldini A, Charnsangavej C, Chan L (1994) Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc Natl Acad Sci U S A 91:8522-8526.
18. Li WH (1997) Molecular evolution. Sunderland (Massachusetts): Sinauer Associates. 487 p.
19. Liao W, Hong SH, Chan BHJ, Rudolph FB, Clark SC, et al. (1999) APOBEC-2, a cardiac- and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem Biophys Res Commun 260: 398-404.
20. Madani N, Kabat D (1998) An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol 72: 10251-10255.
21. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
22. Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, et al. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114: 21-31.
23. Marin M, Rose KM, Kozak SL, Kabat D (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9: 1398-1403.
24. Mian IS, Moser MJ, Holley WR, Chatterjee A (1998) Statistical modelling and phylogenetic analysis of a deaminase domain. J Comput Biol 5: 57-72.
25. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274: 18470-18476.
26. Nakamuta M, Oka K, Krushkal J, Kobayashi K, Yamamoto M, et al. (1995) Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. J Biol Chem 270: 13042-13056.
27. Navaratnam N, Fujino T, Bayliss J, Jarmuz A, How A, et al. (1998) Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition. J Mol Biol 275: 695-714.
28. Nei M, Glazko GV (2002) The Wilhelmine E. Key 2001 invitational lecture. Estimation of divergence times for a few mammalian and several primate species. J Hered 93: 157-164.
29. Peeters M, Courgnaud V (2002) Overview of primate lentiviruses and their evolution in non-human primates in Africa. HIV Sequence Database. Available: http://www.hiv.lanl.gov/content/hiv-db/REVIEWS/ PEETERS2002/Peeters2002.html via the Internet. Accessed 1 July 2004.
30. Polson AG, Bass BL, Casey JL (1996) RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 380: 454-456.
31. Purvis A (1995) A composite estimate of primate phylogeny. Philos Trans R Soc Lond B Biol Sci 348: 405-421.
32. Schrofelbauer B, Chen D, Landau NR (2004) A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc Natl Acad Sci U S A 101: 3927-3932.
33. Selker EU, Tountas NA, Cross SH, Margolin BS, Murphy JG, et al. (2003) The methylated component of the Neurospora crassa genome. Nature 422: 893-897.
34. Sharp PM, Bailes E, Robertson DL, Gao F, Hahn BH (1999) Origins and evolution of AIDS viruses. Biol Bull 196: 338-342.
35. Sheehy AM, Gaddis NC, Choi JD, Malim MH (2002) Isolation of a human gene that inhibits HIV-1 infection and is supressed by the viral Vif protein. Nature 418: 646-650.
36. Sheehy AM, Gaddis NC, Malim MH (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9: 1404-1407.
37. Simon JH, Gaddis NC, Fouchier RA, Malim MH (1998) Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 4: 1397-1400.
38. Stopak K, de Noronha C, Yonemoto W, Greene WC (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12: 591-601.
39. Tabara H, Sarkissian M, Kelly WG, Fleenor J, Grishok A, et al. (1999) The rde-1 gene, RNA interference, and transposon silencing in C. elegans. Cell 99: 123-132.
40. Tamaru H, Selker EU (2001) A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 414: 277-283.
41. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882.
42. Turelli P, Mangeat B, Jost S, Vianin S, Trono D (2004) Inhibition of hepatitis B virus replication by APOBEC3G. Science 303: 1829.
43. Vartanian JP, Sommer P, Wain-Hobson S (2003) Death and the retrovirus. Trends Mol Med 9: 409-413.
44. Wedekind JE, Dance GSC, Sowden MP, Smith HC (2003) Messenger RNA editing in mammals: New members of the APOBEC family seeking roles in the family business. Trends Genet 19: 207-216.
45. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR (2004) A second human antiretroviral factor, Apobec3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J 23: 2451-2458.
46. Yang Z (1997) PAML: A program package for phylogenetic analysis by maximum likelihood. Comput Appl Biosci 13: 555-556.
47. Yang Z, Swanson WJ (2002) Codon-substitution models to detect adaptive evolution that account for heterogeneous selective pressures among site classes. Mol Biol Evol 19: 49-57.
48. Yu XH, Yu YK, Liu BD, Luo K, Kong W, et al. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302: 1056-1060.
49. Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, et al. (2003) The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424: 94-98.
50. Zheng YH, Irwin D, Kurosu T, Tokunaga K, Sata T, et al. (2004) Human Apobec3F is another host factor that blocks human immunodeficiency virus type 1 replication. J Virol 78: 6073-6076.